KCT0007584
Completed
未知
Clinical trial to evaluate efficacy and safety of low molecular collagen peptides for joint pain
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yonsei University Health System, Severance Hospital
- Enrollment
- 78
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Adult men and women aged 40 years or older and less than 75 years old for more than 6 months after being diagnosed with knee arthritis
- •(2\) Those whose Kellgren\-Lawrence grading scale of one or both knee joints is grade I or II in simple radiographic examination
- •(3\) Those who have knee arthritis pain score of 30 mm or more evaluated by the Visual analog scale (VAS\-100 mm)
- •(4\) Those with a body mass index (BMI) of less than 30 kg/m2
Exclusion Criteria
- •(1\) Those who have been diagnosed with inflammatory arthritis such as rheumatoid arthritis or lupus arthritis, or have been diagnosed with secondary osteoarthritis due to systemic disease, etc.
- •(2\) Those with gout, recurrent pseudogout
- •(3\) Those who have infection or severe inflammation of the knee joint, such as septic arthritis
- •(4\) If there is a lower extremity fracture within the last 3 months
- •(5\) Persons with a history of clinically significant hypersensitivity to collagen components
- •(6\) Those who cannot stop taking drugs or health functional foods that affect knee joint pain during the test period from 2 weeks before the first intake of food for human application testing
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Clinical trial to evaluate efficacy and safety of KCS03 stent in a native coronary lesioStable angina, unstable angina and non-ST elevated myocardial infarction with de novo or restenotic coronary lesionsJPRN-UMIN000010422Kaneka Corporation115
Completed
Phase 2
Clinical trial to evaluate efficacy and safety of cyclophosphamide, bortezomib and dexamethasone (CBD) induction and autologous stem cell transplantation for patients for newly diagnosed multiple myeloma (NBMT-ASCT1201)multiple myelomaJPRN-UMIN000008399Toyohashi Municipal Hospital Division of Hematology and Oncology54
Completed
Phase 3
Clinical trial to evaluate efficacy and safety of apheresis therapy on peripheral arterial disease with critical limb ischemia.Peripheral arterial diseaseJPRN-UMIN000020336Kaneka Corporation61
Recruiting
Phase 3
Clinical trial to evaluate safety and efficacy of radiofrequency ablation for malignant tumors located outside the livermalignant tumors which have lesions located outside the liverJPRN-UMIN000012109Division of Diagnostic Imaging and Minimally Invasive Therapy, Juntendo University Graduate School of Medicine20
Recruiting
Not Applicable
Clinical trial to evaluate safety and efficacy of the C2 CryoBalloon 180° Ablation System for the treatment of dysplastic Barrett*s esophagus: CBAS180 de-escalation studyBarrett's esophagusBarrett's neoplasia10017990NL-OMON52660Pentax Medical122